CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and h… Read more
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.237x
Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.237x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-987.91 Million) by net assets (CN¥4.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CSPC Innovation Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Innoviva Inc
NASDAQ:INVA
|
0.046x |
|
Co-Tech Development
TWO:8358
|
0.000x |
|
ISA ENERGIA BRASIL
SA:ISAE3
|
-0.028x |
|
Landis+Gyr Group AG
OTCGREY:LGYRF
|
-0.031x |
|
XiaMen HongXin Electron-tech Co Ltd
SHE:300657
|
-0.095x |
|
Veris Residential Inc
NYSE:VRE
|
0.011x |
|
Transcend Information Inc
TW:2451
|
0.123x |
|
Orora Ltd
AU:ORA
|
0.082x |
Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2024)
The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.50 Billion | CN¥-1.24 Billion | -0.275x | -250.71% |
| 2023-12-31 | CN¥5.09 Billion | CN¥927.24 Million | 0.182x | +12.20% |
| 2022-12-31 | CN¥3.94 Billion | CN¥640.72 Million | 0.162x | +181.90% |
| 2021-12-31 | CN¥2.96 Billion | CN¥170.59 Million | 0.058x | -55.64% |
| 2020-12-31 | CN¥2.69 Billion | CN¥349.07 Million | 0.130x | -0.51% |
| 2019-12-31 | CN¥2.42 Billion | CN¥315.38 Million | 0.131x | -18.30% |
| 2018-12-31 | CN¥999.35 Million | CN¥159.73 Million | 0.160x | +9327.66% |
| 2017-12-31 | CN¥766.93 Million | CN¥1.30 Million | 0.002x | -99.29% |
| 2016-12-31 | CN¥572.02 Million | CN¥137.27 Million | 0.240x | +34.25% |
| 2015-12-31 | CN¥626.83 Million | CN¥112.05 Million | 0.179x | +2.85% |
| 2014-12-31 | CN¥537.16 Million | CN¥93.36 Million | 0.174x | -- |